Agios Pharmaceuticals, Inc. (AGIO)

Agios Pharmaceuticals Stock Forecast

Stock Price Forecast

The 8 analysts that cover Agios Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $36.63, which forecasts a 26.48% increase in the stock price over the next year. The lowest target is $25 and the highest is $65.

Price Target: $36.63 (+26.48%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$25	$36.63	$38	$65
Change	-13.67%	+26.48%	+31.22%	+124.45%

Analyst Ratings

The average analyst rating for Agios Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	1	1	4	4	4	4
Buy	4	4	2	1	1	1
Hold	1	1	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	9	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $62 → $65	Strong Buy	Maintains	$62 → $65	+124.45%	Feb 12, 2026
Tessa Romero JP Morgan	JP Morgan	Hold Maintains $20 → $25	Hold	Maintains	$20 → $25	-13.67%	Jan 6, 2026
Andrew Berens Leerink Partners	Leerink Partners	Buy Maintains $34 → $40	Buy	Maintains	$34 → $40	+38.12%	Dec 26, 2025
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $48 → $62	Strong Buy	Maintains	$48 → $62	+114.09%	Dec 24, 2025
Gregory Renza Truist Securities	Truist Securities	Strong Buy Maintains $32 → $38	Strong Buy	Maintains	$32 → $38	+31.22%	Dec 24, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

109.72M

Increased by 103.08%

from 54.03M

Revenue Next Year

248.70M

Increased by 126.67%

from 109.72M

EPS This Year

-6.60

from -7.12

EPS Next Year

-5.30

from -6.60

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	14.24M	26.82M	36.50M	54.03M	109.72M	248.70M
Revenue Growth	-	-	88.36%	36.07%	48.03%	103.08%	126.67%
EPS	26.55	-4.23	-6.33	11.64	-7.12	-6.60	-5.30
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	12	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	200.6M	437.9M
Avg	109.7M	248.7M
Low	64.7M	128.4M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	271.2%	299.1%
Avg	103.1%	126.7%
Low	19.7%	17.0%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	-5.06	-3.48
Avg	-6.60	-5.30
Low	-7.42	-6.67

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.